Abstract
In this study, 10% Marigold leaf extract was tested for possible genotoxicity by looking at mitotic aberrations. The study aimed to determine potential variations in the incidence of mitotic chromosomal abnormalities by comparing two groups: one group was treated with 10% Marigold leaf extract, and the other group received no therapy. The control group had a total of 37% mitotic chromosomal abnormalities, which included 24% structural abnormalities and 13% disruptive abnormalities. Conversely, On the other hand, the treatment group (who received a 10% Marigold leaf extract) exhibited a total of 53.00% mitotic aberrations, of which 25.00% were structural and 28.00% were disruptive. Compared to the control group, this percentage of anomalies was substantially (P<0.01) higher.10% of marigold leaf extract may be genotoxic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal For Multidisciplinary Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
